publication venue for
- Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression 2022
- When to prescribe oral anticoagulation for patients with device-detected subclinical atrial fibrillation? Insights from the NOAH-AFNET 6 and ARTESiA trials. 123:52-54. 2024
- Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?. 122:40-41. 2024
- Routine measurement of DOAC concentrations for prognostication and clinical management in acute ischemic stroke: Is it ready for prime time?. 113:18-19. 2023
- Pregnancy-related venous thromboembolism: Progress but questions remain. 97:32-33. 2022
- Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?. 96:13-16. 2022
- Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. 92:100-106. 2021
- What is the role of growth-differentiation factor-15 in biomarker-based prediction of mortality in patients with atrial fibrillation?. 88:23-24. 2021
- Postoperative atrial fibrillation after non-cardiac surgery: How important is it and what do we do about it?. 85:25-26. 2021
- Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration. 82:97-104. 2020
- Is aspirin safer than a direct oral anticoagulant for patients with atrial fibrillation at high risk of bleeding?. 79:25-26. 2020
- The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive value. 78:26-27. 2020
- Fifty years of research on antithrombotic therapy: Achievements and disappointments. 70:1-7. 2019
- North America anticoagulation forum guidance on reversal of direct oral anticoagulants. 67:30-32. 2019
- Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis. 61:29-33. 2019
- Validation of the BAP-65 score for prediction of in-hospital death or use of mechanical ventilation in patients presenting to the emergency department with an acute exacerbation of COPD: a retrospective multi-center study from the Italian Society of Emergency Medicine (SIMEU). 61:62-68. 2019
- Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients. 57:25-31. 2018
- PoliFIT-INFOcus: A pilot study exploring how to promote physical activity in older people. 57:e41-e42. 2018
- Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries. 55:28-34. 2018
- COPD exacerbations in the emergency department: Epidemiology and related costs. A retrospective cohort multicentre study from the Italian Society of Emergency Medicine (SIMEU). 51:74-79. 2018
- Does rhythm or rate control strategy influence anticoagulant treatment in older patients with atrial fibrillation? Data from REPOSI. 44:e18-e19. 2017
- Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study. 33:55-59. 2016
- Predictors of clinical events occurring during hospital stay among elderly patients admitted to medical wards in Italy. 32:38-42. 2016
- Relationships of iron metabolism with insulin resistance and glucose levels in young and healthy adults. 32:31-37. 2016
- Gender difference in drug use in hospitalized elderly patients. 26:483-490. 2015
- Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia. 26:330-337. 2015
- Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 26:243-249. 2015
- Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 25:847-852. 2014
- Altered mental status in older adults with histamine2-receptor antagonists: A population-based study. 25:701-709. 2014
- Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study. 25:617-623. 2014
- Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 24:800-806. 2013
- Risk factors for hospital readmission of elderly patients. 24:45-51. 2013
- Polypathological patients and prognostic scores. 23:e36-e37. 2012
- Association between clusters of diseases and polypharmacy in hospitalized elderly patients: Results from the REPOSI study. 22:597-602. 2011
- More about optimal choices in cardioembolism prevention. 22:e19-e19. 2011
- Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. 22:205-210. 2011
- Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. 21:516-523. 2010
- Barriers to obesity treatment. 19:173-180. 2008